Inventor
BRIMBLE MARGARET ANNE
NZ22 patents
⚠️ This page may combine multiple inventors who share the name “BRIMBLE MARGARET ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUREN PHARMACEUTICALS LTD
6 patentsUS7714020B2May 11, 2010
Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
NEUREN PHARMACEUTICALS LTD18 citations86
US7863304B2Jan 4, 2011
Analogs of glycyl-prolyl-glutamate
NEUREN PHARMACEUTICALS LTD8 citations82
US7041314B2May 9, 2006
GPE analogs and peptidominetics
NEUREN PHARMACEUTICALS LTD13 citations82
US7605177B2Oct 20, 2009
Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
NEUREN PHARMACEUTICALS LTD14 citations79
US7776876B2Aug 17, 2010
Cyclic G-2Allylproline in treatment of Parkinson's disease
NEUREN PHARMACEUTICALS LTD6 citations73
US7485630B2Feb 3, 2009
Neuroprotective macrocyclic compounds and methods for their use
NEUREN PHARMACEUTICALS LTD0 citations49
AUCKLAND UNISERVICES LTD
3 patentsUS10576144B2Mar 3, 2020
Amino acid and peptide conjugates and conjugation process
AUCKLAND UNISERVICES LTD2 citations66
US11014960B2May 25, 2021
Amino acid and peptide conjugates and uses thereof
AUCKLAND UNISERVICES LTD0 citations57
US11464853B2Oct 11, 2022
Amino acid and peptide conjugates and conjugation process
AUCKLAND UNISERVICES LTD0 citations46
OTAGO INNOVATION LTD
3 patentsUS11072584B2Jul 27, 2021
Carbon monoxide releasing norbornenone compounds
OTAGO INNOVATION LTD0 citations52
US10494344B2Dec 3, 2019
Carbon monoxide releasing norbornenone compounds
OTAGO INNOVATION LTD1 citations52
US11691949B2Jul 4, 2023
Quinoline sulfonamide compounds and their use as antibacterial agents
OTAGO INNOVATION LTD0 citations39